Dose-escalation trial shows local control with low toxicity, low leptomeningeal recurrence
Companion studies reveal efficacy indicators for PD-1/PD-L1 inhibition
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy